Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SNBP

Sun BioPharma (SNBP) Stock Price, News & Analysis

About Sun BioPharma Stock (NASDAQ:SNBP)

Key Stats

Today's Range
N/A
50-Day Range
$3.45
$4.50
52-Week Range
N/A
Volume
49,422 shs
Average Volume
26,926 shs
Market Capitalization
$3.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.

Receive SNBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sun BioPharma and its competitors with MarketBeat's FREE daily newsletter.

SNBP Stock News Headlines

Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
See More Headlines

SNBP Stock Analysis - Frequently Asked Questions

Sun BioPharma, Inc. (NASDAQ:SNBP) issued its earnings results on Thursday, November, 12th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.09.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sun BioPharma investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Processa Pharmaceuticals (PCSA), Akero Therapeutics (AKRO), Athabasca Oil (ATH), Black Iron (BKI) and Berry (BRY).

Company Calendar

Last Earnings
11/12/2020
Today
11/12/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SNBP
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3.96 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:SNBP) was last updated on 11/12/2024 by MarketBeat.com Staff
From Our Partners